or Try an Advanced Search...

    Depressive Disorder Stocks List

    Symbol Grade Name % Change
    BMY B Bristol-Myers Squibb Company 1.10
    BWAY B Brainsway Ltd. 1.63
    ALKS B Alkermes plc 3.90
    ITCI C Intra-Cellular Therapies Inc. 0.28
    PRAX C Praxis Precision Medicines, Inc. 1.97
    VNDA C Vanda Pharmaceuticals Inc. 3.04
    ABBV D AbbVie Inc. 3.04
    PFE D Pfizer, Inc. 2.07
    AZN D Astrazeneca PLC 2.13
    LLY F Eli Lilly and Company -0.25
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
    Related Stock Lists: Major Depressive Disorder Biopharmaceutical Neuroscience Schizophrenia Hypertension S&P 500 Alzheimer's Disease Bipolar Disorder Cholesterol Depression Diabetes Dysfunction Hyperactivity Disorder Mental Health Obsessive Compulsive Disorder Pharmaceutical Products Psychiatry Treatment Of Major Depressive Disorder Alcohol Anemia

    Related ETFs - A few ETFs which own one or more of the above listed Depressive Disorder stocks.

    Symbol Grade Name Weight
    IWC B iShares Microcap ETF 0.02
    View all Depressive Disorder ETFs...
    Compare ETFs

        Depressive Disorder Stocks Recent News

        Date Stock Title
        Nov 22 LLY Sanofi Plans to Change Hospital Drug-Discount Program
        Nov 22 ABBV AbbVie gains on Leerink Partners upgrade to Outperform
        Nov 22 ABBV AbbVie: Upgrading To 'Strong Buy' After Pullback
        Nov 22 PFE Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales View
        Nov 22 AZN Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales View
        Nov 22 PFE BridgeBio heart drug approved by FDA, setting up battle with Pfizer
        Nov 22 PFE Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics
        Nov 22 PFE FDA Accepts Bayer's Application for Label Expansion of Nubeqa
        Nov 22 PFE Pfizer Inc. (PFE) Jefferies London Healthcare Conference (Transcript)
        Nov 22 ABBV J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
        Nov 22 BMY AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
        Nov 22 ABBV AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
        Nov 22 PFE Replimune Stock Rallies on BLA Filing for Melanoma Combo Drug
        Nov 22 ABBV AbbVie upgraded to outperform by Leerink on recent sell-off
        Nov 22 LLY VKTX Stock Loses Over $1B in a Month: How to Play the Stock?
        Nov 22 LLY Investing in Pharma Stocks? Check These 3 Things First
        Nov 22 LLY Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry?
        Nov 22 PFE RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?
        Nov 22 PFE Zai Lab and Pfizer to commercialise XACDURO in China
        Nov 22 LLY Goldman Sachs: Eli Lilly and Company (LLY) Is A Top Growth Investor Stock
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
        Related Stock Lists: Antidepressants Major Depressive Disorder Treatment Of Major Depressive Disorder Biopharmaceutical Cartilage Central Nervous System Disease Chemical Entities Clinical Development Clinical Pharmacology Clinical Trial Disease Disorders Drug Discovery Drug Metabolism Drugs Health Sciences In Vitro Insomnia Investigational New Drug Ketones
        Depressive Disorder

        Depressive disorder, also known as major depressive disorder or clinical depression, is a mental health condition characterized by persistent feelings of sadness, hopelessness, and worthlessness. Symptoms can include changes in sleep, appetite, energy levels, concentration, and self-esteem. People with depressive disorder may also experience physical symptoms such as headaches, digestive problems, and chronic pain. Treatment typically involves a combination of medication, psychotherapy, and lifestyle changes.

        Browse All Tags